MedTrace Logo

Pilot to Examine Risk and Feasibility of Remote Management of BP From CKD Through ESRD

NCT02975505 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2025-02-17

Study results available
· View outcomes & findings →

Summary

The transition from chronic kidney disease (CKD) to end-stage renal disease ESRD is a vulnerable and challenging period of time for patients and providers. Suboptimal control of blood pressure is known to be common in patients with the advanced stages of CKD, and may contribute to their elevated risk of progression to ESRD, cardiovascular morbidity, and mortality. This proposal is a pilot randomized controlled trial designed to test whether intensive home blood pressure lowering is feasible and safe in patients with advanced CKD as they transition to ESRD.

Conditions

Interventions

OTHER

Strict blood pressure control

Systolic Blood Pressure Target \< 120 mm Hg (measured at home)

Sponsors & Collaborators

Principal Investigators

  • Raymond Hsu, MD MAS · University of California, San Francisco

  • Elaine Ku, MD MAS · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-10
Primary Completion
2021-07-18
Completion
2021-07-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02975505 on ClinicalTrials.gov